Disease is always generated, experienced, defined, and ameliorated within a social world. Patients need notions of disease that explicate their suffering. Doctors need theories of etiology and pathophysiology that account for the burden of disease and inform therapeutic practice. Policymakers need realistic understandings of determinants of disease and medicine's impact in order to design systems that foster health. The history of disease offers crucial insights into the intersections of these interests and the ways they can inform medical practice and health policy.
Epidemiologic transitions
In addition to angina, diarrhea, and burns, early Journal issues examined gunshot wounds, spina bifida, Tetralogy of Fallot, diabetes, hernia, epilepsy, osteomyelitis, syphilis, cancer, croup, asthma, rabies, and urethral stones. Although some case reports describe patients who might walk into urgent care today, others are nearly unrecognizable. Apoplexy, a syndrome of fainting spells that might mean stroke, seizure, or syncope today, was understood to arise from a "nervous sympathy" by which the stomach influenced the head (1812d). Doctors agreed that even a near miss by a cannonball --without contact --could shatter bones, blind people, or even kill them (1812f). Reports of spontaneous combustion, especially of "brandy-drinking men and women," received serious, if skeptical, consideration (1812g). And physicians were obsessed with fevers -puerperal, petechial, catarrhal, even an outbreak of "spotted fever" in which some patients were neither spotted nor febrile (1812e). The bill of mortality from 1811 (see extract) contains both the familiar and the exotic (1812h).
Consumption, diarrhea, and pneumonia dominated the mortality data, but teething, worms, and drinking cold water apparently killed as well.
A century later, the infections that filled the Journal had been redefined according to specific microbial causes. The Journal ran reviews of tuberculosis (1912b) , gonorrhea (1912e) , and syphilis (1912i) . Diphtheria, measles, pneumonia, scarlet fever, and typhoid made frequent cameos, and Massachusetts still maintained a leper colony on Penikese Such paeans to progress, however, were accompanied by fear of the morbid consequences of modernization. One article described a new problem, "automobile knee," and decried the prevalence of "persons of extremely indolent habits of life" who no longer walked more "than the few steps that are needed from the chamber to the elevator, from the elevator to the dining-room, or lounging-room, and then to the automobile"(1912j). Long-standing concern about epilepsy, alcoholism, and feeblemindedness took on new relevance in a society increasingly preoccupied by fears of race suicide and the promise of eugenics (1912g, 1912h) . Doctors struggled with cancers, eclampsia, impotence, heart disease (chiefly infectious or valvular, rather than atherosclerotic), and arthritis.
During the 20th century, heart disease, cancer, and other chronic conditions assumed more dominant roles (see graph), though outbreaks of infectious disease, from eastern equine encephalitis (1938) and kuru (1957) to legionnaires' disease (1977) , AIDS (1981) , and multidrug-resistant tuberculosis (1993) , necessitated ongoing vigilance against microbes. New concerns also came to medical attention, from the terrifying consequences of thermonuclear war (1962) to the indolent but devastating effects of environmental pollution (1966) and climate change (1989) . Optimism about prospects for future health persisted but remained tempered by concern about the pathologies of civilization. An obesity epidemic, feared in 1912, has come to pass. Our previously steady increase in life expectancy has stalled and may even reverse (2005) .
Definitions and consequences
The material and conceptual dynamism of disease poses challenges: how do we define disease meaningfully, and how do we measure our burden of disease and set health policy priorities? These are deceptively simple questions.
Merriam-Webster's Medical
Dictionary's definition of disease as "an impairment of the normal state of the living animal or plant body" begs the question: What is normal? What is impaired? We cannot answer by reference to biology alone: the line between normal and pathological requires value judgments. As physicians know, not every symptom constitutes a disease. Nor, as anthropologists have shown, is it feasible simply to contrast "disease," as diagnosed by doctors, with "illness," as experienced by patients. * As contemporary disputes over alcoholism, chronic fatigue syndrome, and attention-deficit disorder make clear, physicians are never the sole arbiters of disease.
Any responsible attempt to define disease must account for the phenomenon's complexity. A disease has characteristic signs and symptoms, afflicts particular groups of people, and follows a characteristic course. Genetic screening has led to dramatic reductions in Tay-Sachs disease, thalassemia, and familial dysautonomia (2009) . But often the potential for eradication has been incompletely realized -witness the continued prevalence of AIDS and tuberculosis in low-income countries and of atherosclerotic heart disease globally.
Even as prevailing diseases have changed, health disparities have endured.
Inequalities in health status have always existed, regardless of how health has been measured or populations defined. When Europeans arrived in the Americas, they witnessed stark disparities in the fates of European, American, and African populations.
Experiencing the ravages of 19th-century industrialization, physicians grew familiar with health disparities between rich and poor. Health inequalities remain ubiquitous, not just among races and ethnic groups, but also according to geography, sex, educational level, occupation, income, and other gradients of wealth and power. 4 The persistence of health inequalities challenges our scientific knowledge and political will. Can we explain them and alleviate them? Genetic variations don't explain why mortality rates double as you cross Boston Harbor from Back Bay to Charlestown or walk up Fifth Avenue from midtown Manhattan into Harlem. Nor do they explain why Asian-American women in Bergen County, New Jersey, live 50% longer than Native
American men in South Dakota. 5 Although we know something about the relationships among poverty, stress, allostatic load, and the hypothalamic-pituitary-adrenal axis, doctors and epidemiologists need more precise models that fill in the steps between social exposure, disease, and death.
Accounting for the history of disease also requires us to examine why some disparities in disease are seen as proof of a natural order while others are considered evidence of injustice. The 4.3-year life-expectancy gap between blacks and whites in the U.S. provokes outrage, but the 4.9-year gap between men and women does not. It's tempting to assume that differences between the sexes are natural and those between races aren't. But a 19th-century Journal reader might be skeptical of this explanation:
men then lived at least as long as women. The survival advantage of women that appeared in the 20th century owed as much to changes in childbearing, improvements in obstetrical practice, and a new epidemic of heart disease disproportionally affecting men as to differences between X and Y chromosomes. Health and disease disparities are contingent outcomes of the ways society structures the lives and risks of individuals.
Recognition of the contingency of health inequalities should make them a target for intervention, yet the opposite has frequently happened: the ill health of impoverished or marginalized groups has been used against them -as evidence of their inferiority or as an argument that they're unworthy of assistance. Such sentiments drove tragic government policies toward African-Americans and Native Americans in the late 19th
and early 20th centuries. They may underlie current policies that would limit health care access for mentally ill, impoverished, or immigrant populations.
The roles of medicine
Medical practice and health policy rely on the assumption that the solution to the problem of disease is to be found in physicians and their therapies. Physicians tend to credit biomedical science with 20th-century improvements in health and longevity. The history, however, is complex and contested.
For example, after Robert Koch's 1882 discovery of Mycobacterium tuberculosis and the advent of antibiotics in the 1940s, physicians claimed responsibility for the decline of tuberculosis in Europe and North America. But closer examination revealed that this decline had begun before Koch's discovery and had largely run its course before effective antibiotics became available. Medicine's critics instead credited improvements in the standard of living, especially diet. A similar debate has emerged about coronary artery disease. Heart disease, like tuberculosis, followed a century-long epidemic wave, peaking in the United States in the 1960s before beginning 50 years of decline.
Researchers have struggled to determine how much credit to give to health care or riskfactor reduction (2007) . The decline narrative and debates, however, have been complicated by countries, notably the Russian Federation and China, where coronary disease has recently increased, and by signs of a plateau and possible reversal of decline in the United States, Australia, and Western Europe (2005) . The stakes of this debate are substantial, with implications for allocation of contested health care resources.
Is there a best health policy? Our goal should be an integrated policy under which health care and public health programs together fully eclipse the disease burden (see diagram). But the details depend on how we conceptualize and measure disease. And disease is never static. Just as organisms evolve to keep up with changing environmental conditions (the "Red Queen Effect"), medicine struggles to keep up with the changing burden of disease. Since therapeutic innovation takes time, the burden shifts even as solutions appear. By the time antibiotics and vaccines began combating infectious diseases, mortality had shifted toward heart disease, cancer, and stroke. Great progress has been made against these challenges, but the burden of disease will surely shift again.
We already face increasing neuropsychiatric disease for which satisfying treatments don't yet exist.
In many respects, our medical systems are best suited for diseases of the past, not those of the present or future. We must continue to adapt health systems and health policy as the burden of disease evolves. But we must also do more. Diseases can never be reduced to molecular pathways, mere technical problems requiring treatments or cures. Disease is a complex domain of human experience, involving explanation, expectation, and meaning. Doctors must acknowledge this complexity and formulate theories, practices, and systems that fully address the breadth and subtlety of disease.
